Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection

Chisari, 1989, Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice, Cell, 59, 1145, 10.1016/0092-8674(89)90770-8 Geller, 1994, Hepatocarcinogenesis is the sequel to hepatitis in Z#2α1-antitrypsin transgenic mice: histopathological and DNA ploidy studies, Hepatology, 19, 389, 10.1002/hep.1840190218 Hino, 1991, Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA, Proc Natl Acad Sci USA, 83, 8338, 10.1073/pnas.83.21.8338 Wang, 1990, Hepatitis B virus integration in a cyclin A gene in a human hepatocellular carcinoma, Nature, 343, 555, 10.1038/343555a0 Humbel, 1990, Insulin-like growth factors I and II, Eur J Biochem, 190, 445, 10.1111/j.1432-1033.1990.tb15595.x De Pagter-Holthuizen, 1987, The human insulin-like growth factor II contains two development-specific promoters, FEBS Lett, 214, 259, 10.1016/0014-5793(87)80066-2 De Pagter-Holthuizen, 1988, Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein, Biochim Biophys Acta, 950, 282, 10.1016/0167-4781(88)90124-8 Holthuizen, 1990, Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene, Biochim Biophys Acta, 1087, 341, 10.1016/0167-4781(90)90010-Y Li, 1996, Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters, J Endocrinol, 149, 117, 10.1677/joe.0.1490117 Li, 1997, Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma, Cancer Res, 57, 2048 Baserga, 1995, The insulin-like growth factor I receptor: a key to tumor growth?, Cancer Res, 55, 249 Zarrilli, 1994, Multiple levels of control of the insulin-like growth factor gene expression, Mol Cell Endocrinol, 101, R1, 10.1016/0303-7207(94)90253-4 Zarrilli, 1994, Expression insulin-like growth factor II (IGF-II) and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells, Cell Growth Differ, 5, 1085 Alexia, 2004, An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis, Biochem Pharmacol, 68, 1003, 10.1016/j.bcp.2004.05.029 Norstedt, 1988, Expression of insulin-like growth factor-I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat, Carcinogenesis, 9, 209, 10.1093/carcin/9.2.209 Schirmacher, 1992, Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth, Cancer Res, 52, 2549 Casola, 1995, Loss of heterozygosity of imprinted genes in SV 40 t/T antigen-induced hepatocellular carcinomas, Oncogene, 11, 711 Yang, 1991, Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry, Carcinogenesis, 12, 1893, 10.1093/carcin/12.10.1893 Yang, 1993, Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers, Cancer Res, 53, 2020 Christofiori, 1994, A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis, Nature, 369, 414, 10.1038/369414a0 Harris, 1998, Reactivation of the maternally imprinted IGF2 allele in TGF alpha induced hepatocellular carcinomas in mice, Oncogene, 16, 203, 10.1038/sj.onc.1201519 Sohda, 1996, Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level, Lab Invest, 75, 307 Sohda, 1997, Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: relationship to fatty change in carcinoma cells, J Gastroenterol Hepatol, 12, 224, 10.1111/j.1440-1746.1997.tb00412.x Sohda, 1998, In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma, J Hum Genet, 43, 49, 10.1007/s100380050036 Ng, 1998, Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma, J Gastroenterol Hepatol, 13, 152, 10.1111/j.1440-1746.1998.tb00630.x Breuhahn, 2004, Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression, Cancer Res, 64, 6058, 10.1158/0008-5472.CAN-04-0292 d’Arville, 1991, Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma, Hepatology, 13, 310, 10.1002/hep.1840130217 Su, 1994, Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression, Hepatology, 20, 788, 10.1002/hep.1840200404 Seo, 1995, Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma, Gan To Kagaku Ryoho, 22, 292 Desmet, 1994, Classification of chronic hepatitis: diagnosis, grading, and staging, Hepatology, 19, 1513, 10.1002/hep.1840190629 Edmondson, 1954, Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies, Cancer, 7, 462, 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E Nardone, 1996, Activation of fetal promoters of insulin-like growth factor II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma, Hepatology, 23, 1304, 10.1002/hep.510230602 Mineo, 2000, Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon, Biochem Biophys Res Commun, 268, 886, 10.1006/bbrc.2000.2225 Pei, 1988, Differential stability of c-myc mRNAs in a cell-free system, Mol Cell Biol, 8, 2860, 10.1128/MCB.8.7.2860 Buendia, 2000, Genetics of hepatocellular carcinoma, Semin Cancer Biol, 10, 185, 10.1006/scbi.2000.0319 Vu, 1996, Alterations in the promoter-specific Imprinting of the insulin-like growth factor-II gene in Wilms’ tumor, J Biol Chem, 271, 9014, 10.1074/jbc.271.30.18253 Wu, 1997, Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas, Biochem Biophys Res Commun, 235, 123, 10.1006/bbrc.1997.6744 Zhang, 1996, Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis, Cancer Res, 56, 1367 Uchida, 1997, Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma, Mol Carcinog, 18, 193, 10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F Cariani, 1990, Expression of insulin like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis, J Hepatol, 11, 226, 10.1016/0168-8278(90)90118-B Takeda, 1996, Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease, Oncogene, 12, 1589 Bae, 1999, Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia, Cancer Res, 59, 5989 Lee, 1998, The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4, Oncogene, 16, 2367, 10.1038/sj.onc.1201760 Lee, 2001, Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites, Virology, 283, 167, 10.1006/viro.2001.0892 Lee, 2000, Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma, Oncogene, 19, 3717, 10.1038/sj.onc.1203694 Dittmer, 1993, Gain of function mutations in p53, Nat Genet, 4, 42, 10.1038/ng0593-42 Hsiao, 1994, Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness, Am J Pathol, 145, 702 Lewis, 2005, The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma, Mol Cell Biol, 25, 1228, 10.1128/MCB.25.4.1228-1237.2005 Izumi, 1994, Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection, Gastroenterology, 106, 720, 10.1016/0016-5085(94)90707-2